Use of 2-D DIGE analysis reveals altered phosphorylation in a tropomyosin mutant (Glu54Lys) linked to dilated cardiomyopathy

Proteomics

Volumn 8, Issue 1, 2008, Pages 100-105

  Warren, Chad M ^a   Arteaga, Grace M ^a   Rajan, Sudarsan ^b   Ahmed, Rafeeq P H ^b   Wieczorek, David F ^b   Solaro, R John ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

2 D DIGE; Familial cardiomyopathies; Kinases; Phosphatases; Sarcomere

Indexed keywords

GLUTAMIC ACID DERIVATIVE; LYSINE DERIVATIVE; TROPOMYOSIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; GENE MUTATION; HEART; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; TRANSGENIC MOUSE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

AMINO ACID SUBSTITUTION; ANIMALS; CARDIOMYOPATHY, DILATED; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GLUTAMIC ACID; IMMUNOBLOTTING; LYSINE; MICE; MICE, TRANSGENIC; PHOSPHORYLATION; POINT MUTATION; TROPOMYOSIN;

MUS MUSCULUS;

EID: 38149014016     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200700772     Document Type: Article

References (22)

1. Ashrafian, H., Watkins, H., Reviews of translational medicine and genomics in cardiovascular disease: new disease taxonomy and therapeutic implications cardiomyopathies: therapeutics based on molecular phenotype. J. Am. Coll. Cardiol. 2007, 49, 1251-1264.
2. Muthuchamy, M., Pieples, K., Rethinasamy, P., Hoit, B. et al., Mouse model of a familial hypertrophic cardiomyopathy mutation in alpha-tropomyosin manifests cardiac dysfunction. Circ. Res. 1999, 85, 47-56.
3. Prabhakar, R., Boivin, G. P., Grupp, I. L., Hoit, B. et al., A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice. J. Mol. Cell. Cardiol. 2001, 33, 1815-1828.
4. Rajan, S., Ahmed, R. P., Jagatheesan, G., Petrashevskaya, N. et al., Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity. Circ. Res. 2007.
5. Biesiadeck,i B. J., Kobayashi, T., Walker, J. S., Solaro, R. J., de Tombe, P. P., The troponin C G159D mutation blunts myofilament desensitization induced by troponin I Ser23/24 phosphorylation. Circ. Res. 2007, 100, 1486-1493.
6. Kobayashi, T., Dong, W. J., Burkart, E. M., Cheung, H. C., Solaro, R. J., Effects of protein kinase C dependent phosphorylation and a familial hypertrophic cardiomyopathy-related mutation of cardiac troponin I on structural transition of troponin C and myofilament activation. Biochemistry 2004, 43, 5996-6004.
7. Layland, J., Cave, A. C., Warren, C., Grieve, D. J. et al., Protection against endotoxemia-induced contractile dysfunction in mice with cardiac-specific expression of slow skeletal troponin I. FASEB J. 2005, 19, 1137-1139.
8. Fritz, J. D., Swartz, D. R., Greaser, M. L., Factors affecting Polyacrylamide gel electrophoresis and electroblotting of high-molecular-weight myofibrillar proteins. Anal. Biochem. 1989, 180, 205-210.
9. Porzio, M. A., Pearson, A. M., Improved resolution of myofibrillar proteins with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Biochim. Biophys. Acta 1977, 490, 27-34.
10. Baumann, G., Chrambach, A., A highly crosslinked, transparent polyacrylamide gel with improved mechanical stability for use in isoelectric focusing and isotachophoresis. Anal. Biochem. 1976, 70, 32-38.
11. Shevchenko, A., Wilm, M., Vorm, O., Mann, M., Mass spectrometry sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 1996, 68, 850-858.
12. Mak, A., Smillie, L. B., Barany, M., Specific phosphorylation at serine-283 of alpha tropomyosin from frog skeletal and rabbit skeletal and cardiac muscle. Proc. Natl. Acad. Sci. USA 1978, 75, 3588-3592.
13. Heeley, D. A., Moir, A. J, Perry, S. V., Phosphorylation of tropomyosin during development in mammalian striated muscle. FEBS Lett. 1982, 146, 115-118.
14. Gaffin, R. D., Gokulan, K., Sacchettini, J. C., Hewett, T. et al., Charged residue changes in the carboxy-terminus of alpha-tropomyosin alter mouse cardiac muscle contractility. J. Physiol. 2004, 556, 531-543.
15. 2+, strong cross-bridge binding, and protein phosphorylation. J. Biol. Chem. 1996, 271, 11611-11614.
16. Vahebi, S., Ota, A., Li, M., Warren, C. M. et al., p38-MAPK induced dephosphorylation of alpha-tropomyosin is associated with depression of myocardial sarcomeric tension and ATPase activity. Circ. Res. 2007, 100, 408-415.
17. Kobayashi, T., Solaro, R. J., Calcium, thin filaments, and the integrative biology of cardiac contractility. Annu. Rev. Physiol. 2005, 67, 39-67.
18. Mirza, M., Robinson, P., Kremneva, E., Copeland, O. et al., The effect of mutations in alpha-tropomyosin (E40K and E54K) that cause familial dilated cardiomyopathy on the regulatory mechanism of cardiac muscle thin filaments. J. Biol. Chem. 2007, 282, 13487-13497.
19. Heeley, D. H., Investigation of the effects of phosphorylation of rabbit striated muscle alpha alpha-tropomyosin and rabbit skeletal muscle troponin-T. Eur. J. Biochem. 1994, 221, 129-137.
20. Heeley, D. H., Watson, M. H., Mak, A. S., Dubord, P., Smillie, L. B., Effect of phosphorylation on the interaction and functional properties of rabbit striated muscle alpha alpha-tropomyosin. J. Biol. Chem. 1989, 264, 2424-2430.
21. Sano, K., Maeda, K., Oda, T., Maeda, Y., The effect of single residue substitutions of serine-283 on the strength of head-to-tail interaction and actin binding properties of rabbit skeletal muscle alpha-tropomyosin. J. Biochem. (Tokyo) 2000, 127, 1095-1102.
22. Rao, V., La Bonte, L. R., Xu, Y., Yang, Z. et al., Alterations to myofibrillar protein function in non-ischemic regions of the heart early after myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 2007, 293, H654-H659.